🔎 Trials Near Me

Почетна › Плоскоклеточни карцином главе и врата › Kalifornija › Irvine

Kliničke studije za Плоскоклеточни карцином главе и врата u gradu Irvine, CA

11 studija za Плоскоклеточни карцином главе и врата traži učesnike na lokacijama u gradu Irvine i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Тражи се учесникФаза 2
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05136196

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Тражи се учесникФаза 1
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07503808

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Тражи се учесникФаза 1
  • City of Hope at Irvine Lennar, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07090499

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Тражи се учесникФаза 1
  • City of Hope at Irvine Lennar, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07156227

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Тражи се учесникФаза 1/2
  • City of Hope, Irvine, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07109726

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Тражи се учесникФаза 2
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06980038

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Тражи се учесникФаза 2
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT02734537

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

Тражи се учесникФаза 1
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278432, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT07241039

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Тражи се учесникФаза 1
  • Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT05208762

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Тражи се учесникФаза 1
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 23. 6. 2026. · NCT05005403

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

Тражи се учесникФаза 1/2
  • University of California, Irvine, Irvine
Узраст 18 и старији · Оба пола · Ажурирано 20. 12. 2024. · NCT05877430

Studije za Плоскоклеточни карцином главе и врата u drugim gradovima

Ostale studije u gradu Irvine

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.